Tong Ren Tang Technologies Stock Forecast for 2023 - 2025 - 2030

Updated on 05/05/2024

Stock Rating
14
Price Target
HK$6.06
Consensus
Outperform
Upside
11.19%
Analysts
0
Stock Rating
14
Upside
11.19%
Analysts
0
Price Target
HK$6.06

Tong Ren Tang Technologies Stock Forecast and Price Target

The average price target for Tong Ren Tang Technologies's stock of HK$6.06 recently provided by leading analysts would represent a 11.19% upside from its last closing price if reached. This potential increase is based on a high estimate of HK$6.48 and a low estimate of HK$5.64. If you're looking for Tong Ren Tang Technologies (1666) stock information, you might also want to check out China Resources Double-Crane Pharmaceutical (SHSE:600062).

HK$6.06

11.19% Upside

Outperform
Outperform

Tong Ren Tang Technologies Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Tong Ren Tang Technologies's Price has decreased by 100.00%, from HK$5.48 to HK$0.00. In the next year, analysts predict that Fair Value will jump to HK$8.44 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.

2024 Fair Value Forecast
HK$8.44
2025 Fair Value Forecast
HK$8.29
2026 Fair Value Forecast
HK$8.34
2027 Fair Value Forecast
HK$5.59
2028 Fair Value Forecast
HK$6.53
2029 Fair Value Forecast
HK$7.27
2030 Fair Value Forecast
HK$7.87
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600276 Stock Forecast Jiangsu Hengrui Medicine Buy 15
¥46.16 Buy/Sell ¥56.49 16.98%
T14 Stock Forecast Tianjin Pharmaceutical Da Ren ... Outperform 18
$34.99 Buy/Sell $1.70 30.89%
600436 Stock Forecast Zhangzhou Pientzehuang Pharmac... Outperform 18
¥237.24 Buy/Sell ¥302.86 19.10%
000538 Stock Forecast Yunnan Baiyao Group Co.,Ltd Outperform 18
¥57.25 Buy/Sell ¥65.39 11.79%
1093 Stock Forecast CSPC Pharmaceutical Group Buy 18
HK$6.76 Buy/Sell HK$9.50 37.57%

Tong Ren Tang Technologies Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Tong Ren Tang Technologies's Revenue has grown, moving from HK$4.61B to HK$5.99B – an increase of 30.05%. In the next year, analysts predict that Revenue will jump to HK$7.75B – up 29.27% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 30.24%.

2024 Rev Forecast
HK$7.75B
2025 Rev Forecast
HK$8.95B
2026 Rev Forecast
HK$7.58B
2027 Rev Forecast
HK$7.12B
2028 Rev Forecast
HK$7.39B
2029 Rev Forecast
HK$7.90B
2030 Rev Forecast
HK$7.80B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000999 Stock Forecast China Resources Sanjiu Medical... Buy 18
¥59.97 Buy/Sell ¥65.95 13.62%
600085 Stock Forecast Beijing Tongrentang Outperform 16
¥42.33 Buy/Sell ¥61.18 27.57%
600196 Stock Forecast Shanghai Fosun Pharmaceutical ... Outperform 16
¥23.67 Buy/Sell ¥33.57 20.83%

Tong Ren Tang Technologies Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Tong Ren Tang Technologies's Dividend per Share has fallen from HK$0.16 to HK$0.16 – a 0.00% decrease. According to 2 prominent analysts, Tong Ren Tang Technologies's Dividend per Share will fall by 37.50% in the next year, reaching HK$0.10. By 2030, professionals believe that Tong Ren Tang Technologies's Dividend per Share will decrease by 100.00%, reaching HK$0.00 – a concerning trend for the company.

2024 DPS Forecast
HK$0.10
2025 DPS Forecast
HK$0.00
2026 DPS Forecast
HK$0.00
2027 DPS Forecast
HK$0.00
2028 DPS Forecast
HK$0.00
2029 DPS Forecast
HK$0.00
2030 DPS Forecast
HK$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002294 Stock Forecast Shenzhen Salubris Pharmaceutic... Buy 18
¥31.92 Buy/Sell ¥35.65 15.91%
600079 Stock Forecast Humanwell Healthcare (Group) Buy 0
¥20.25 Buy/Sell ¥32.49 -100.00%
000513 Stock Forecast Livzon Pharmaceutical Group Outperform 18
¥36.98 Buy/Sell ¥39.23 11.41%

Tong Ren Tang Technologies Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600518 Stock Forecast Kangmei Pharmaceutical - 6
¥1.99 Buy/Sell ¥25.97 -100.00%
300146 Stock Forecast Byhealth Outperform 15
¥15.84 Buy/Sell ¥26.39 29.42%
002262 Stock Forecast Jiangsu Nhwa Pharmaceutical Co... Buy 18
¥25.01 Buy/Sell ¥31.34 23.95%

Tong Ren Tang Technologies EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, EBITDA for Tong Ren Tang Technologies has grown by 19.72%, going from HK$1.16B to HK$1.39B. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach HK$1.65B – an increase of 18.27%. Over the next seven years, experts anticipate that EBITDA growth for Tong Ren Tang Technologies will be 7.13%.

2024 EBITDA Forecast
HK$1.65B
2025 EBITDA Forecast
HK$1.56B
2026 EBITDA Forecast
HK$1.43B
2027 EBITDA Forecast
HK$1.43B
2028 EBITDA Forecast
HK$1.50B
2029 EBITDA Forecast
HK$1.52B
2030 EBITDA Forecast
HK$1.49B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
900904 Stock Forecast Shanghai Shenqi Pharmaceutical... - 13
$6.53 Buy/Sell $0.00 -100.00%
600062 Stock Forecast China Resources Double-Crane P... Buy 16
¥21.77 Buy/Sell ¥26.00 18.24%
600380 Stock Forecast Joincare Pharmaceutical Group ... Buy 18
¥11.61 Buy/Sell ¥14.72 26.79%

Tong Ren Tang Technologies EBIT Forecast for 2023 - 2025 - 2030

Tong Ren Tang Technologies's EBIT has grown in the last two years, jumping from HK$965.85M to HK$1.21B – an increase of 25.60%. In the next year, analysts predict that EBIT will reach HK$1.47B – an increase of 20.89%. For the next seven years, the forecast is for EBIT to grow by 9.25%.

2024 EBIT Forecast
HK$1.47B
2025 EBIT Forecast
HK$1.41B
2026 EBIT Forecast
HK$1.27B
2027 EBIT Forecast
HK$1.26B
2028 EBIT Forecast
HK$1.33B
2029 EBIT Forecast
HK$1.35B
2030 EBIT Forecast
HK$1.33B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002773 Stock Forecast Chengdu Kanghong Pharmaceutica... Buy 11
¥21.70 Buy/Sell ¥24.00 -100.00%
600867 Stock Forecast Tonghua Dongbao Pharmaceutical Buy 18
¥10.09 Buy/Sell ¥14.25 45.49%
603858 Stock Forecast Shandong Buchang Pharmaceutica... - 18
¥16.85 Buy/Sell ¥0.00 -100.00%

Tong Ren Tang Technologies EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Tong Ren Tang Technologies's EPS has decreased by 100.00%, from HK$0.37 to HK$0.00. In the next year, analysts predict that EPS will jump to HK$0.57 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.

2024 EPS Forecast
HK$0.57
2025 EPS Forecast
HK$0.56
2026 EPS Forecast
HK$0.56
2027 EPS Forecast
HK$0.38
2028 EPS Forecast
HK$0.44
2029 EPS Forecast
HK$0.49
2030 EPS Forecast
HK$0.53
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000623 Stock Forecast Jilin Aodong Pharmaceutical Gr... Buy 16
¥15.28 Buy/Sell ¥0.00 48.36%
600422 Stock Forecast KPC Pharmaceuticals,Inc Buy 18
¥22.72 Buy/Sell ¥28.00 10.08%
000766 Stock Forecast Tonghua Golden-Horse Pharmaceu... - 11
¥17.16 Buy/Sell ¥33.00 -100.00%